Alaina GetzenbergMar 14, 2025, 05:14 PM ET
- Alaina Getzenberg covers the Buffalo Bills for ESPN. She joined ESPN in 2021. Alaina was previously a beat reporter for the Charlotte Observer and has also worked for CBS Sports and the Dallas Morning News. She is a graduate of the University of California, Berkeley.
ORCHARD PARK, N.Y. -- The Buffalo Bills will be without two of their free agent additions -- defensive tackle Larry Ogunjobi and defensive end Michael Hoecht -- for the first six games of the season due to testing positive for performance enhancing drugs.
Bills general manager Brandon Beane shared the update during a press conference on Friday afternoon. The positive tests would violate the NFL's policy against PEDs.
Both players will be able to stay with the team through the offseason program and training camp and then can return to the building after four weeks and play after six.
The team was aware of Hoecht's suspension in advance of agreeing to terms with Bills. Hoecht, who was brought in on a three-year deal, found out he had tested positive three weeks into the offseason for "some form of testosterone in my system," so was able to give interested teams in free agency advance notice on what he was facing going into the 2025 season.
Objunobi, however, only found about his positive test during free agency week and the Bills were not aware before agreeing to terms. Beane said that Ogunjobi came into his office on Thursday and discussed the matter with him. It caused a delay in his one-year contract signing, but they elected to move forward with many other defensive tackles off the market.
Comments